Patent · US Active

Leukotriene B4 binding soluble lipocalin receptor from ixodes ricinus

US8324161B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignees

Inventors

Edmond Godfroid · Brussels, BE
Jérôme Beaufays · Braine-le-Comte, BE
Luc Vanhamme · Court-Saint-Etienne, BE
Benoît Adam · Brussels, BE
Laurence Lins · Vieusart, BE
Sébastien Santini · Vienne, FR
Robert Brasseur · Haillot, BE

Key dates

Filing date	Sep 10, 2008
Grant date	Dec 4, 2012
Priority date	—
Expiry date	Sep 10, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/43527
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Leukotriene B4 binding polypeptide is obtained from Ixodes ricinus. Leukotriene B4 polypeptide, the polynucleotide encoding Leukotriene B4 polypeptide, and Leukotriene B4 polypeptide related polypeptides may be used as research reagents and for treatments and diagnostics specific to animal and human diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.